Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2,2-bis(4-hydroxy-3-tert-butylphenyl)propane
- Development stage
- Preclinical
- Modality
- Small Molecules
01
Overview
2,2-bis(4-hydroxy-3-tert-butylphenyl)propane is a synthetic small molecule belonging to the bisphenol class of organic compounds. It has been investigated in clinical trials for the treatment of adenocarcinoma. The compound features two phenolic groups substituted with tert-butyl groups and an isopropylidene bridge. Its mechanism of action and pharmacological profile are not fully characterized in public sources; it may act as an antioxidant or modulator of cellular pathways due to its structural similarity to other bisphenols[1][2]. No approved therapeutic indications or established mechanisms are currently documented.
- Other names
- 2,2-bis(4-hydroxy-3-tert-butylphenyl)propane4,4'-Isopropylidenebis(o-tert-butylphenol)UNII-OKF3E6VGQBUNII-OKF-3E6VGQBUNII-OKF 3E6VGQBEINECS 201-239-5EINECS201-239-5EINECS-201-239-5
Beyond the preview
Go deeper on 2,2-bis(4-hydroxy-3-tert-butylphenyl)propane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2,2-bis(4-hydroxy-3-tert-butylphenyl)propane.